Literature DB >> 20538960

A candidate gene study of obstructive sleep apnea in European Americans and African Americans.

Emma K Larkin1, Sanjay R Patel, Robert J Goodloe, Yali Li, Xiaofeng Zhu, Courtney Gray-McGuire, Mark D Adams, Susan Redline.   

Abstract

RATIONALE: Obstructive sleep apnea (OSA) is hypothesized to be influenced by genes within pathways involved with obesity, craniofacial development, inflammation, and ventilatory control.
OBJECTIVES: We conducted the first candidate gene study of OSA using family data from European Americans and African Americans, selecting biologically plausible genes from within these pathways.
METHODS: A total of 1,080 single nucleotide polymorphisms (SNPs) were genotyped in 729 African Americans and 505 SNPs were genotyped in 694 European Americans. Coding for SNPs additively, association testing on the apnea-hypopnea index (AHI) as a continuous trait, and OSA as a dichotomous trait (AHI ≥15) was conducted using methods that account for familial correlations in models adjusted for age, age-squared, and sex, with and without body mass index.
MEASUREMENTS AND MAIN RESULTS: In European Americans, variants within C-reactive protein (CRP) and glial cell line-derived neurotrophic factor (GDNF) were associated with AHI (CRP: β = 4.6; SE = 1.1; P = 0.0000402) (GDNF: β = 4.3; SE = 1; P = 0.0000201) and with the dichotomous OSA trait (CRP: odds ratio = 2.4; 95% confidence interval, 1.5-3.9; P = 0.000170) (GDNF: odds ratio = 2; 95% confidence interval, 1.4-2.89; P = 0.0000433). In African Americans, rs9526240 within serotonin receptor 2a (HTR2A: odds ratio = 2.1; 95% confidence interval, 1.5-2.9; P = 0.00005233) was associated with OSA.
CONCLUSIONS: This candidate gene analysis identified the potential role of genes operating through intermediate disease pathways to influence sleep apnea phenotypes, providing a framework for focusing future replication studies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20538960      PMCID: PMC2970865          DOI: 10.1164/rccm.201002-0192OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  34 in total

1.  Upper airway muscle inflammation and denervation changes in obstructive sleep apnea.

Authors:  John H Boyd; Basil J Petrof; Qutayba Hamid; Richard Fraser; R John Kimoff
Journal:  Am J Respir Crit Care Med       Date:  2004-05-19       Impact factor: 21.405

2.  Obstructive sleep apnea in family members.

Authors:  K P Strohl; N A Saunders; N T Feldman; M Hallett
Journal:  N Engl J Med       Date:  1978-11-02       Impact factor: 91.245

3.  Pharmacological characterization of serotonergic receptor activity in the hypoglossal nucleus.

Authors:  Polina Fenik; Sigrid C Veasey
Journal:  Am J Respir Crit Care Med       Date:  2002-08-22       Impact factor: 21.405

4.  Elevated C-reactive protein in patients with obstructive sleep apnea.

Authors:  Abu S M Shamsuzzaman; Mikolaj Winnicki; Paola Lanfranchi; Robert Wolk; Tomas Kara; Valentina Accurso; Virend K Somers
Journal:  Circulation       Date:  2002-05-28       Impact factor: 29.690

5.  Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure.

Authors:  Takuya Yokoe; Kenji Minoguchi; Hirofumi Matsuo; Naruhito Oda; Hideko Minoguchi; Gen Yoshino; Tsutomu Hirano; Mitsuru Adachi
Journal:  Circulation       Date:  2003-03-04       Impact factor: 29.690

6.  The relationship between craniofacial morphology and obstructive sleep apnea in whites and in African-Americans.

Authors:  B Cakirer; M G Hans; G Graham; J Aylor; P V Tishler; S Redline
Journal:  Am J Respir Crit Care Med       Date:  2001-03       Impact factor: 21.405

Review 7.  Genetic aspects of the obstructive sleep apnoea/hypopnoea syndrome--is there a common link with obesity?

Authors:  Renata L Riha
Journal:  Respiration       Date:  2009-07-08       Impact factor: 3.580

8.  Systemic administration of serotonin 2A/2C agonist improves upper airway stability in Zucker rats.

Authors:  Toshiyuki Ogasa; Andrew D Ray; Charles P Michlin; Gaspar A Farkas; Brydon J B Grant; Ulysses J Magalang
Journal:  Am J Respir Crit Care Med       Date:  2004-07-15       Impact factor: 21.405

9.  Whole genome scan for obstructive sleep apnea and obesity in African-American families.

Authors:  Lyle J Palmer; Sarah G Buxbaum; Emma K Larkin; Sanjay R Patel; Robert C Elston; Peter V Tishler; Susan Redline
Journal:  Am J Respir Crit Care Med       Date:  2004-04-07       Impact factor: 21.405

10.  A whole-genome scan for obstructive sleep apnea and obesity.

Authors:  Lyle J Palmer; Sarah G Buxbaum; Emma Larkin; Sanjay R Patel; Robert C Elston; Peter V Tishler; Susan Redline
Journal:  Am J Hum Genet       Date:  2002-12-23       Impact factor: 11.025

View more
  38 in total

1.  Genetic underpinnings of obstructive sleep apnea: are we making progress?

Authors:  Patrick Sleiman; Hakon Hakonarson
Journal:  Sleep       Date:  2011-11-01       Impact factor: 5.849

2.  Identification of novel mouse genes conferring posthypoxic pauses.

Authors:  C Barton Gillombardo; Motoo Yamauchi; Mark D Adams; Jesse Dostal; Sam Chai; Michael W Moore; Lucas M Donovan; Fang Han; Kingman P Strohl
Journal:  J Appl Physiol (1985)       Date:  2012-04-26

3.  Relationship of obstructive sleep apnea syndrome with the 5-HT2A receptor gene in Brazilian patients.

Authors:  Thiago Bittencourt Ottoni de Carvalho; Marcela Suman; Fernando Drimel Molina; Vânia Belintani Piatto; José Victor Maniglia
Journal:  Sleep Breath       Date:  2012-01-27       Impact factor: 2.816

4.  Variants in C-reactive protein and IL-6 genes and susceptibility to obstructive sleep apnea in children: a candidate-gene association study in European American and Southeast European populations.

Authors:  Athanasios G Kaditis; David Gozal; Abdelnaby Khalyfa; Leila Kheirandish-Gozal; Oscar Sans Capdevila; Konstantinos Gourgoulianis; Emmanouel I Alexopoulos; Konstantinos Chaidas; Rakesh Bhattacharjee; Jinkwan Kim; Paraskevi Rodopoulou; Elias Zintzaras
Journal:  Sleep Med       Date:  2013-12-04       Impact factor: 3.492

Review 5.  The role inflammatory response genes in obstructive sleep apnea syndrome: a review.

Authors:  Francisco Fábio Ferreira de Lima; Diego R Mazzotti; Sergio Tufik; Lia Bittencourt
Journal:  Sleep Breath       Date:  2015-07-23       Impact factor: 2.816

6.  The National Center on Sleep Disorders Research-progress and promise.

Authors:  James P Kiley; Michael J Twery; Gary H Gibbons
Journal:  Sleep       Date:  2019-06-11       Impact factor: 5.849

Review 7.  Understanding Pathophysiological Concepts Leading to Obstructive Apnea.

Authors:  Eric Deflandre; Alexander Gerdom; Christine Lamarque; Bernard Bertrand
Journal:  Obes Surg       Date:  2018-08       Impact factor: 4.129

Review 8.  The Role of Big Data in the Management of Sleep-Disordered Breathing.

Authors:  Rohit Budhiraja; Robert Thomas; Matthew Kim; Susan Redline
Journal:  Sleep Med Clin       Date:  2016-03-16

9.  A community-oriented framework to increase screening and treatment of obstructive sleep apnea among blacks.

Authors:  Natasha J Williams; Girardin Jean-Louis; Joeseph Ravenell; Azizi Seixas; Nadia Islam; Chau Trinh-Shevrin; Gbenga Ogedegbe
Journal:  Sleep Med       Date:  2015-09-25       Impact factor: 3.492

10.  Genetic Associations with Obstructive Sleep Apnea Traits in Hispanic/Latino Americans.

Authors:  Brian E Cade; Han Chen; Adrienne M Stilp; Kevin J Gleason; Tamar Sofer; Sonia Ancoli-Israel; Raanan Arens; Graeme I Bell; Jennifer E Below; Andrew C Bjonnes; Sung Chun; Matthew P Conomos; Daniel S Evans; W Craig Johnson; Alexis C Frazier-Wood; Jacqueline M Lane; Emma K Larkin; Jose S Loredo; Wendy S Post; Alberto R Ramos; Ken Rice; Jerome I Rotter; Neomi A Shah; Katie L Stone; Kent D Taylor; Timothy A Thornton; Gregory J Tranah; Chaolong Wang; Phyllis C Zee; Craig L Hanis; Shamil R Sunyaev; Sanjay R Patel; Cathy C Laurie; Xiaofeng Zhu; Richa Saxena; Xihong Lin; Susan Redline
Journal:  Am J Respir Crit Care Med       Date:  2016-10-01       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.